Kamran Khan1, M Mustafa Hirji2, Jennifer Miniota2, Wei Hu2, Jun Wang2, Michael Gardam2, Sameer Rawal2, Edward Ellis2, Angie Chan2, Maria I Creatore2, Elizabeth Rea2. 1. Department of Medicine (Khan, Gardam), Division of Infectious Diseases, University of Toronto; Centre for Research on Inner City Health (Khan, Miniota, Creatore, Chan, Hu, Wang), Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ont.; Public Health and Preventive Medicine Residency Program (Hirji), Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ont.; Infection Prevention and Control (Gardam), University Health Network; Faculty of Medicine (Rawal), University of Toronto, Toronto, Ont.; Faculty of Medicine (Ellis), University of Ottawa, Ottawa, Ont.; Toronto Public Health and Dalla Lana School of Public Health (Rea), University of Toronto, Toronto, Ont. khank@smh.ca. 2. Department of Medicine (Khan, Gardam), Division of Infectious Diseases, University of Toronto; Centre for Research on Inner City Health (Khan, Miniota, Creatore, Chan, Hu, Wang), Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ont.; Public Health and Preventive Medicine Residency Program (Hirji), Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ont.; Infection Prevention and Control (Gardam), University Health Network; Faculty of Medicine (Rawal), University of Toronto, Toronto, Ont.; Faculty of Medicine (Ellis), University of Ottawa, Ottawa, Ont.; Toronto Public Health and Dalla Lana School of Public Health (Rea), University of Toronto, Toronto, Ont.
Abstract
BACKGROUND: All Canadian immigrants undergo screening for tuberculosis (TB) before immigration, and selected immigrants must undergo postimmigration surveillance for the disease. We sought to quantify the domestic health impact of screening for TB in all new immigrants and to identify mechanisms to enhance effectiveness and efficiency of this screening. METHODS: We linked preimmigration medical examination records from 944,375 immigrants who settled in Ontario between 2002 and 2011 to active TB reporting data in Ontario between 2002 and 2011. Using a retrospective cohort study design, we measured birth country-specific rates of active TB detected through preimmigration screening and postimmigration surveillance. We then quantified the proportion of active TB cases among residents of Ontario born abroad that were detected through postimmigration surveillance. Using Cox regression, we identified independent predictors of active TB postimmigration. RESULTS: Immigrants from 6 countries accounted for 87.3% of active TB cases detected through preimmigration screening, and 10 countries accounted for 80.4% of cases detected through postimmigration surveillance. Immigrants from countries with a TB (all-sites) incidence rate of less than 30 cases per 100 000 persons resulted in pre- and postimmigration detection of 2.4 and 0.9 cases per 100 000 immigrants, respectively. Postimmigration surveillance detected 2.6% of active TB cases in Ontario residents born abroad, and TB was detected a median of 18 days earlier in those undergoing surveillance than in those who were not referred to surveillance or who did not comply. Predictors of active TB postimmigration included radiographic markers of old TB, birth country, immigration category, location of application for residency, immune status and age. INTERPRETATION: Universal screening for TB in new immigrants has a modest impact on the domestic burden of active TB and is highly inefficient. Focusing preimmigration screening in countries with high incidence rates and revising criteria for postimmigration surveillance could increase the effectiveness and efficiency of screening.
BACKGROUND: All Canadian immigrants undergo screening for tuberculosis (TB) before immigration, and selected immigrants must undergo postimmigration surveillance for the disease. We sought to quantify the domestic health impact of screening for TB in all new immigrants and to identify mechanisms to enhance effectiveness and efficiency of this screening. METHODS: We linked preimmigration medical examination records from 944,375 immigrants who settled in Ontario between 2002 and 2011 to active TB reporting data in Ontario between 2002 and 2011. Using a retrospective cohort study design, we measured birth country-specific rates of active TB detected through preimmigration screening and postimmigration surveillance. We then quantified the proportion of active TB cases among residents of Ontario born abroad that were detected through postimmigration surveillance. Using Cox regression, we identified independent predictors of active TB postimmigration. RESULTS: Immigrants from 6 countries accounted for 87.3% of active TB cases detected through preimmigration screening, and 10 countries accounted for 80.4% of cases detected through postimmigration surveillance. Immigrants from countries with a TB (all-sites) incidence rate of less than 30 cases per 100 000 persons resulted in pre- and postimmigration detection of 2.4 and 0.9 cases per 100 000 immigrants, respectively. Postimmigration surveillance detected 2.6% of active TB cases in Ontario residents born abroad, and TB was detected a median of 18 days earlier in those undergoing surveillance than in those who were not referred to surveillance or who did not comply. Predictors of active TB postimmigration included radiographic markers of old TB, birth country, immigration category, location of application for residency, immune status and age. INTERPRETATION: Universal screening for TB in new immigrants has a modest impact on the domestic burden of active TB and is highly inefficient. Focusing preimmigration screening in countries with high incidence rates and revising criteria for postimmigration surveillance could increase the effectiveness and efficiency of screening.
Authors: Catherine Yang; Abdool S Yasseen; Jennifer Stimec; Elizabeth Rea; Valerie Waters; Ray Lam; Shaun K Morris; Ian Kitai Journal: CMAJ Open Date: 2018-08-28
Authors: Lisa A Ronald; Jonathon R Campbell; Robert F Balshaw; Kamila Romanowski; David Z Roth; Fawziah Marra; Victoria J Cook; James C Johnston Journal: CMAJ Date: 2018-02-26 Impact factor: 8.262
Authors: Lisa A Ronald; Jonathon R Campbell; Robert F Balshaw; David Z Roth; Kamila Romanowski; Fawziah Marra; Victoria J Cook; James C Johnston Journal: BMJ Open Date: 2016-11-25 Impact factor: 2.692
Authors: Jonathon R Campbell; James C Johnston; Mohsen Sadatsafavi; Victoria J Cook; R Kevin Elwood; Fawziah Marra Journal: PLoS One Date: 2017-10-30 Impact factor: 3.240
Authors: Jonathon R Campbell; James C Johnston; Victoria J Cook; Mohsen Sadatsafavi; R Kevin Elwood; Fawziah Marra Journal: Emerg Infect Dis Date: 2019-04 Impact factor: 6.883
Authors: Richard Long; Leyla Asadi; Courtney Heffernan; James Barrie; Christopher Winter; Mary Lou Egedahl; Catherine Paulsen; Brenden Kunimoto; Dick Menzies Journal: PLoS One Date: 2019-03-08 Impact factor: 3.240
Authors: Elissa Rennert-May; Elisabeth Hansen; Toktam Zadeh; Valerie Krinke; Stan Houston; Ryan Cooper Journal: Can Respir J Date: 2016-02-24 Impact factor: 2.409